Download presentation
Presentation is loading. Please wait.
Published byRonald Stephens Modified over 5 years ago
1
Pigmentation after using topical tacrolimus to treat lichen sclerosus: Possible role of stem cell factor Young Jin Kim, MD, Hee Young Kang, MD, PhD Journal of the American Academy of Dermatology Volume 57, Issue 5, Pages S125-S127 (November 2007) DOI: /j.jaad Copyright © 2007 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 A, Hypopigmented patch on right cheek. B, After 3 months of therapy, brownish pigmentation localized at site of tacrolimus application. Journal of the American Academy of Dermatology , S125-S127DOI: ( /j.jaad ) Copyright © 2007 American Academy of Dermatology, Inc. Terms and Conditions
3
Fig 2 Histopathologic and immunohistochemical findings of hyperpigmented skin after tacrolimus use were compared with previous hypopigmented and normal skin. (A-C, Hematoxylin-eosin stain; original magnification: ×100). Fontana-Masson stain (D-F), NKI/beteb detection of epidermal melanocytes (G-I), and reactions with antibodies to stem cell factor (J-L) and vimentin (M-O) are shown. (D-O, Original magnifications: ×200.) Journal of the American Academy of Dermatology , S125-S127DOI: ( /j.jaad ) Copyright © 2007 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.